Immunotherapy in Myeloma : : A Theme Issue in Honor of Prof. Dr. Gösta Gahrton /

Immunotherapy in Myeloma : : A Theme Issue in Honor of Prof. Dr. Gösta Gahrton / / Nicolaus Kröger, Laurent Garderet.

Show other versions (1)

Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Kröger, Nicolaus,
Garderet, Laurent,
TeilnehmendeR:
Garderet, Laurent,
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, [2022]
©2022
Year of Publication:2022
Language:English
Physical Description:1 online resource (124 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • About the Editors
  • Preface to "Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. G ¨osta Gahrton" by Per Ljungman
  • Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gosta Gahrton
  • Why Immunotherapy Fails in Multiple Myeloma
  • Current Status of CAR-T Cell Therapy in Multiple Myeloma
  • Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect
  • Role and Modulation of NK Cells in Multiple Myeloma
  • Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
  • Decades of Progress in Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Similar Items